| Serial Number | 90980667 |
| Word Mark | TPU PHARMA |
| Filing Date | Monday, October 12, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 9, 2024 |
| Registration Number | 7270464 |
| Registration Date | Tuesday, January 9, 2024 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 23, 2021 |
| Goods and Services | Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely, analgesics |
| Disclaimer with Predetermined Text | "PHARMA" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 28, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, November 13, 2023 |
| First Use In Commerce Date | Monday, November 13, 2023 |
| Party Name | Teikoku Pharma USA, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | San Jose, CA 951311711 |
| Party Name | Teikoku Pharma USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Jose, CA 951311711 |
| Party Name | Teikoku Pharma USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Jose, CA 951311711 |
| Event Date | Event Description |
| Tuesday, January 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, January 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Friday, December 8, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, December 7, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, December 1, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, November 14, 2023 | USE AMENDMENT FILED |
| Friday, December 1, 2023 | DIVISIONAL PROCESSING COMPLETE |
| Wednesday, November 29, 2023 | DIVISIONAL REQUEST RECEIVED |
| Tuesday, November 14, 2023 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, November 27, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, November 14, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, May 11, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 9, 2023 | SOU EXTENSION 4 GRANTED |
| Tuesday, May 9, 2023 | SOU EXTENSION 4 FILED |
| Tuesday, May 9, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 17, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 15, 2022 | SOU EXTENSION 3 GRANTED |
| Tuesday, November 15, 2022 | SOU EXTENSION 3 FILED |
| Tuesday, November 15, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 18, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 16, 2022 | SOU EXTENSION 2 GRANTED |
| Monday, May 16, 2022 | SOU EXTENSION 2 FILED |
| Monday, May 16, 2022 | SOU TEAS EXTENSION RECEIVED |
| Saturday, November 13, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 11, 2021 | SOU EXTENSION 1 GRANTED |
| Thursday, November 11, 2021 | SOU EXTENSION 1 FILED |
| Thursday, November 11, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 18, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 23, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 23, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 3, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 16, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 16, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, February 16, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 16, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 16, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Saturday, February 6, 2021 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, February 2, 2021 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Friday, January 15, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 14, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, January 14, 2021 | ASSIGNED TO LIE |
| Wednesday, January 13, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 13, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 13, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, January 8, 2021 | ASSIGNED TO EXAMINER |
| Saturday, November 28, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 15, 2020 | NEW APPLICATION ENTERED |